Speakers: Lena Friberg & Elisabet Nielsen, Department of Pharmaceutical Biosciences, Uppsala University, Sweden
Moderator: Ursula Theuretzbacher, Center for Anti-Infective Agents, Vienna, Austria
In this webinar, Lena Friberg and Elisabet Nielsen discussed:
- Population PK modelling to characterize drug exposure and variability
- PKPD-modelling to characterize preclinical time-kill data
- PKPD-modelling for translation to patients
- Model-based dose-individualization
This live webinar including interactive Q&A session was broadcast on 20 August 2019.
If you have questions or comments, please let us know: firstname.lastname@example.org.